https://www.selleckchem.com/pr....oducts/pf-07321332.h
owever, further studies are needed to confirm these findings. Although patients receiving renal replacement therapy (RRT) have more comorbidities and higher mortality and morbidity risks than the general population, surgery during breast cancer treatment is crucial because of limitations in anticancer agents for patients with renal insufficiency. We aimed to compare the short-term postoperative outcomes between patients with and without RRT. Patients who underwent surgery for stages 0-III breast cancer between July 2010 and March 20
Like
Comment
Share
